Homologous recombination deficiency in PD-L1, PD-L2, Jak2 (PDJ) amplified triple negative breast carcinoma

被引：0
|
作者：
Gawryletz, C. D.
Anderson, K. S.
Northfelt, D. W.
Kosiorek, H. E.
Linnaus, M. E.
Ocal, I. T.
McCullough, A. E.
Pockaj, B. A.
Barrett, M. T.
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Arizona State Univ, Ctr Personalized Diagnost, Biodesign Inst, Tempe, AZ USA
[3] Mayo Clin, Scottsdale, AZ USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P1-05-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-05-19
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Jung, Hae Il
    Jeong, Dongjun
    Ji, Sanghee
    Ahn, Tae Sung
    Bae, Sang Ho
    Chin, Susie
    Chung, Jun Chul
    Kim, Hyung Chul
    Lee, Moon Soo
    Baek, Moo-Jun
    CANCER RESEARCH AND TREATMENT, 2017, 49 (01): : 246 - 254
  • [22] Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar R. Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2016, 128 : 183 - 183
  • [23] Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma
    Dong, Min
    Wang, Hai-yan
    Zhao, Xiao-xiao
    Chen, Jian-ning
    Zhang, Yi-wang
    Huang, Yan
    Xue, Ling
    Li, Hai-gang
    Du, Hong
    Wu, Xiang-yuan
    Shao, Chun-kui
    HUMAN PATHOLOGY, 2016, 53 : 25 - 34
  • [24] Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
    Spirina, Liudmila
    Yurmazov, Zahar
    Usynin, Evgeny
    Kondakova, Irina
    Ladutko, Ekaterine
    Choynzonov, Evgeny
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) : 1072 - 1080
  • [25] PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
    Ghiotto, Marguerite
    Gauthier, Laurent
    Serriari, Nacer
    Pastor, Sonia
    Truneh, Alemseged
    Nunes, Jacques A.
    Olive, Daniel
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (08) : 651 - 660
  • [26] PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
    Yang, Shijie
    Zhang, Qiuyang
    Liu, Sen
    Wang, Alun R.
    You, Zongbing
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2016, 4 (01): : 1 - 8
  • [27] 原发性肝癌PD-L1和PD-L2表达
    王征帆
    王豪勋
    李楠
    赵晓静
    张中冕
    陈香宇
    周士霞
    张玲
    段芳龄
    马军
    医药论坛杂志, 2017, 38 (02) : 14 - 15
  • [28] JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
    Gupta, Sounak
    Cheville, John C.
    Jungbluth, Achim A.
    Zhang, Yanming
    Zhang, Lei
    Chen, Ying-Bei
    Tickoo, Satish K.
    Fine, Samson W.
    Gopalan, Anuradha
    Al-Ahmadie, Hikmat A.
    Sirintrapun, Sahussapont J.
    Blum, Kyle A.
    Lohse, Christine M.
    Hakimi, A. Ari
    Thompson, R. Houston
    Leibovich, Bradley C.
    Berger, Michael F.
    Arcila, Maria E.
    Ross, Dara S.
    Ladanyi, Marc
    Antonescu, Cristina R.
    Reuter, Victor E.
    MODERN PATHOLOGY, 2019, 32 (09) : 1344 - 1358
  • [29] Structural, functional, and evolutionary differences between PD-L1 and PD-L2
    Philips, Elliot A.
    Techova, Anna S.
    Mor, Adam
    Kong, Xiangpeng
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [30] Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer
    Xue, Chunyan
    Zhu, Dawei
    Chen, Lujun
    Xu, Yun
    Xu, Bin
    Zhang, Dachuan
    Jiang, Jingting
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 111 - 119
12345